Rubin Jonathan bought SUPN
September 25, 2025 · Form 4 insider transaction
Rubin Jonathan bought 1,875 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,875
Price
$0.00
Total value
N/A
InsiderRubin Jonathan
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 25, 2025
Filing dateSeptember 26, 2025
Shares owned after11,855
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.